Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...

Purpose To quantify retinal and choriocapillaris (CC) microvasculature in highly myopic (HM) eyes with myopic macular degeneration (MMD) using swept-source optical coherence tomography angiography (SS ...

Myopic tilted disc is a common structural change of myopic eyes. With advancing ocular imaging technology, the associated structural changes of the eye, particularly the optic nerve head, have been ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

Three studies showed that adults aged 20 to 50 years with myopia experienced about –1 D of progression. Most progression occurred between 20 and 30 years of age. Perspective from Alexander ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

At the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing ...